View Author
dai: 074834339
scopus: 34571109400
Leebeek, F.W.G.
(Frank Leebeek)Supervisor (promotor) of 9 dissertations
patient study level factor thrombosis stroke disease blood plasma ischemic stroke platelet control treatment result willebrand protein association ischemic venou d-dimer activity haplotype group thromb table venous thrombosis von willebrand factor signi effect fibrinogen assay signi ficantly analysis disorder risk factors polymorphism variation netherland mutation liver von willebrand disease inhibitor event adamt coagulation population haemost score vwf levels value center diagnosis concentration therapy syndrome number antigen fviii venous thromboembolism portal vein thrombosis sample children university difference embolism aggregation ratio ischaemic stroke budd-chiari syndrome adamts 13 1000521777 | ip portal erasmu thrombotic allele brinogen c 1-inh month platelet aggregation risk factor
10 Most Recent Publications
|
Anticoagulant therapy in patients with non-cirrhotic portal vein thrombosis: Effect on new thrombotic events and gastrointestinal bleeding
(Article)
Spaander, V.M.C.W. Hoekstra, J.W. Hansen, B.E. Buuren, H.R. van Leebeek, F.W.G. Janssen, H.L.A. |
2013-03-01
|
|
Oxidized high-density lipoprotein reduces blood clot firmness
(Article)
Talens, S. Malfliet, J.J.M.C. Leebeek, F.W.G. Rijken, D.C. |
2013-03-01
|
|
Hemophilic arthropathy in patients with von Willebrand disease
(Article)
Galen, K.P.M. van Mauser-Bunschoten E. Leebeek, F.W.G. |
2012-11-01
|
|
Treatment of hereditary angioedema with nanofiltered C1-esterase inhibitor concentrate (Cetor®): Multi-center phase II and III studies to assess pharmacokinetics, clinical efficacy and safety
(Article)
Hofstra, J.J.H. Budde, I.K. Strengers, P.F.W. Twuyver, E. van Choi, G. Levi, M. Leebeek, F.W.G. Monchy, J.G. de Ypma, P.F. Keizer, R.J.W. de Huitema, A.D.R. |
2012-03-01
|
|
Gynaecological and obstetric bleeding in moderate and severe von willebrand disease
(Article)
Wee, E.M. de Knol, H.M. Meijer, K. Leebeek, F.W.G. Mauser-Bunschoten E. Bom, J.G. van der Eikenboom, J. Fijnvandraat, K. Goede-Bolder, A. de Gorkom, B.L.-V. Ypma, P.F. Zweegman, S. |
2011-11-01
|
|
Long-term follow-up of patients with portal vein thrombosis and myeloproliferative neoplasms
(Article)
Hoekstra, J. Bresser, E.L. Smalberg, J.H. Spaander, V.M.C.W. Leebeek, F.W.G. Janssen, H.L.A. |
2011-11-01
|
|
Effect of fibrinolysis on bleeding phenotype in moderate and severe von Willebrand disease
(Article)
Wee, E.M. de Klaij, K. Rijken, D.C. Leebeek, F.W.G. Eikenboom, H.C.J. Bom, J.G. van der Fijnvandraat, K. Laros-Van Gorkom, B.A.P. Mauser-Bunschoten E. Meijer, K. Goverde, G. Linden, P.W.G. van der |
2011-10-06
|
|
Fibrinogen γ' levels in patients with intracerebral hemorrhage
(Article)
Herik, E.G. van den Cheung, E.Y.L. Lau, L. de Hertog, H.M. den Leebeek, F.W.G. Dippel, D.W.J. Koudstaal, P.J. Maat, M.P.M. de |
2011-09-13
|
|
Relationship between thrombospondin gene variations, von Willebrand factor levels and the risk of coronary heart disease in an older population
(Article)
Loon, J.E. van Maat, M.P.M. de Hofman, A. Witteman, J.C.M. Leebeek, F.W.G. |
2011-07-01
|
|
Genetic determinants of von Willebrand factor levels and activity in relation to the risk of cardiovascular disease: A review
(Article)
Schie, M.C. van Loon, J.E. van Maat, M.P.M. de Leebeek, F.W.G. |
2011-05-01
|
